BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pavathuparambil Abdul Manaph N, Sivanathan KN, Nitschke J, Zhou XF, Coates PT, Drogemuller CJ. An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy. Stem Cell Res Ther. 2019;10:293. [PMID: 31547868 DOI: 10.1186/s13287-019-1396-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Khazaei M, Khazaei F, Niromand E, Ghanbari E. Tissue Engineering Approaches and Generation of Insulin-Producing Cells to Treat Type 1 Diabetes. J Drug Target 2022;:1-32. [PMID: 35896313 DOI: 10.1080/1061186X.2022.2107653] [Reference Citation Analysis]
2 Azizi Z, Abbaszadeh R, Sahebnasagh R, Norouzy A, Motevaseli E, Maedler K. Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix? Stem Cell Res Ther 2022;13:348. [PMID: 35883121 DOI: 10.1186/s13287-022-03028-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Dubey A, Saini S, Sharma V, Malik H, Kumar D, De AK, Bhattacharya D, Malakar D. Deducing Insulin-Producing Cells from Goat Adipose Tissue-Derived Mesenchymal Stem Cells. Cell Reprogram 2022. [PMID: 35787695 DOI: 10.1089/cell.2022.0029] [Reference Citation Analysis]
4 Habib SA, Kamal MM, El-Maraghy SA, Senousy MA. Exendin-4 enhances osteogenic differentiation of adipose tissue mesenchymal stem cells through the receptor activator of nuclear factor-kappa B and osteoprotegerin signaling pathway. J Cell Biochem 2022. [PMID: 35338509 DOI: 10.1002/jcb.30236] [Reference Citation Analysis]
5 Alonaizan R, Carr C. Cardiac regeneration following myocardial infarction: the need for regeneration and a review of cardiac stromal cell populations used for transplantation. Biochem Soc Trans 2022:BST20210231. [PMID: 35129611 DOI: 10.1042/BST20210231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hu W, Song X, Yu H, Sun J, Wang H, Zhao Y. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes. Front Endocrinol 2022;12:682145. [DOI: 10.3389/fendo.2021.682145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Choi H, Shinohara M, Ibuki M, Nishikawa M, Sakai Y. Differentiation of Human-Induced Pluripotent Stem Cell-Derived Endocrine Progenitors to Islet-like Cells Using a Dialysis Suspension Culture System. Cells 2021;10:2017. [PMID: 34440786 DOI: 10.3390/cells10082017] [Reference Citation Analysis]
8 Nam YH, Rodriguez I, Shin SW, Shim JH, Kim NW, Kim MC, Jeong SY, Nuankaew W, Hong BN, Kim H, Kang TH. Characteristics of the New Insulin-Resistant Zebrafish Model. Pharmaceuticals (Basel) 2021;14:642. [PMID: 34358068 DOI: 10.3390/ph14070642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Mo Y, Wang Z, Gao J, Yan Y, Ren H, Zhang F, Qi N, Chen Y. Comparative study of three types of mesenchymal stem cell to differentiate into pancreatic β-like cells in vitro. Exp Ther Med 2021;22:936. [PMID: 34335885 DOI: 10.3892/etm.2021.10368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Dai P, Li J, Chen Y, Zhang L, Zhang X, Wang J, Qi G, Zhang Y. Novel Functional Genes Involved in Transdifferentiation of Canine ADMSCs Into Insulin-Producing Cells, as Determined by Absolute Quantitative Transcriptome Sequencing Analysis. Front Cell Dev Biol 2021;9:685494. [PMID: 34262902 DOI: 10.3389/fcell.2021.685494] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Nagaya M, Hasegawa K, Uchikura A, Nakano K, Watanabe M, Umeyama K, Matsunari H, Osafune K, Kobayashi E, Nakauchi H, Nagashima H. Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes. World J Diabetes 2021; 12(4): 306-330 [PMID: 33889282 DOI: 10.4239/wjd.v12.i4.306] [Reference Citation Analysis]
12 Zhankina R, Baghban N, Askarov M, Saipiyeva D, Ibragimov A, Kadirova B, Khoradmehr A, Nabipour I, Shirazi R, Zhanbyrbekuly U, Tamadon A. Mesenchymal stromal/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review. Stem Cell Res Ther 2021;12:229. [PMID: 33823925 DOI: 10.1186/s13287-021-02295-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Afflerbach AK, Kiri MD, Detinis T, Maoz BM. Mesenchymal Stem Cells as a Promising Cell Source for Integration in Novel In Vitro Models. Biomolecules 2020;10:E1306. [PMID: 32927777 DOI: 10.3390/biom10091306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Brovkina O, Dashinimaev E. Advances and complications of regenerative medicine in diabetes therapy. PeerJ 2020;8:e9746. [PMID: 33194345 DOI: 10.7717/peerj.9746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kuncorojakti S, Rodprasert W, Yodmuang S, Osathanon T, Pavasant P, Srisuwatanasagul S, Sawangmake C. Alginate/Pluronic F127-based encapsulation supports viability and functionality of human dental pulp stem cell-derived insulin-producing cells. J Biol Eng 2020;14:23. [PMID: 32855655 DOI: 10.1186/s13036-020-00246-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Soman SS, Vijayavenkataraman S. Applications of 3D Bioprinted-Induced Pluripotent Stem Cells in Healthcare. Int J Bioprint 2020;6:280. [PMID: 33088994 DOI: 10.18063/ijb.v6i4.280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
17 Rungsiwiwut R, Virutamasen P, Pruksananonda K. Mesenchymal stem cells for restoring endometrial function: An infertility perspective. Reprod Med Biol 2021;20:13-9. [PMID: 33488279 DOI: 10.1002/rmb2.12339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Arutyunyan IV, Fatkhudinov TK, Makarov AV, Elchaninov AV, Sukhikh GT. Regenerative medicine of pancreatic islets. World J Gastroenterol 2020; 26(22): 2948-2966 [PMID: 32587441 DOI: 10.3748/wjg.v26.i22.2948] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Kamal MM, Kassem DH. Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges. Front Cell Dev Biol 2020;8:16. [PMID: 32064260 DOI: 10.3389/fcell.2020.00016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]